Adicet Bio ACET Income Statement (2017-2026)

NASDAQ ACET
$9.38 -0.11 (-1.16%)
At close: Aug 20, 2026 · 4:00 PM EDT
Income Statement Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Revenue & Cost
Revenue (Quarter)
3.43M5.47M24.99M
Interest income
Interest Income - Total (Quarter)
2.92M3.00M2.73M2.07M1.68M1.40M1.17M1.52M1.34M1.17M
Interest expenses
Interest Expenses (Quarter)
7.23M0.03M30.82M13.75M13.75M3.85M12.06M5.53M5.22M24.54M4.16M22.04M4.00M3.24M18.21M1.18M0.02M15.04M13.97M
Interest Income - Net (Quarter)
-21.62M-1.16M-19.30M-1.93M-1.56M-16.81M-0.00M1.50M-13.69M-12.80M
Operating Items
Research & Development (Quarter)
11.93M14.66M13.48M16.18M16.57M25.02M26.76M28.36M26.17M24.76M23.90M25.90M26.25M23.27M22.81M28.42M22.85M25.04M17.49M18.45M
Selling, General & Administrative (Quarter)
5.21M6.35M6.80M6.53M6.42M6.55M6.57M6.53M6.63M6.81M6.97M6.95M6.90M7.47M7.07M3.97M5.10M6.85M4.08M3.85M
Other Operating Expenses (Quarter)
19.46M
Operating Expenses (Quarter)
17.14M21.01M20.28M22.71M22.98M31.57M33.32M34.89M52.26M31.57M30.87M32.85M33.15M30.74M29.89M32.39M27.95M31.89M21.57M22.30M
Operating Income (Quarter)
-13.71M-15.54M4.71M-22.71M-22.98M-31.57M-33.32M-34.89M-52.26M-31.57M-30.87M-32.85M-33.15M-30.74M-29.89M-32.39M-27.95M-31.89M-21.57M-22.30M
EBIT (Quarter)
-13.71M-15.54M4.71M-22.71M-22.98M-31.57M-33.32M-34.89M-52.26M-31.57M-30.87M-32.85M-33.15M-30.74M-29.89M-32.39M-27.95M-31.89M-21.57M-22.30M
Non-operating items
Interest & Investment Income (Quarter)
0.00M0.04M0.03M0.33M1.22M2.18M2.67M2.62M2.52M2.18M2.92M3.00M2.73M2.07M1.68M1.40M1.17M1.52M1.34M1.17M
Other Non Operating Income (Quarter)
-0.25M-0.29M-0.10M-0.14M-0.22M-0.46M-0.21M-0.12M-0.14M-0.10M-0.06M-0.05M-0.05M-0.05M-0.01M-0.22M-0.06M-0.13M0.01M-0.06M
Net income details
EBT (Quarter)
-15.82M4.62M-22.54M-22.00M-29.88M-30.88M-32.40M-49.88M-29.90M0.12M88.41M-28.21M-0.03M-26.86M0.05M-20.24M-21.21M
Tax Provisions (Quarter)
0.01M-0.01M-24.53M0.14M
Profit After Tax (Quarter)
-14.01M-15.81M4.62M-22.54M-22.00M-29.88M-30.88M-32.40M-49.88M-29.49M-28.02M-29.90M-30.36M-28.85M-28.21M-31.22M-26.86M-30.43M-20.38M-21.43M
Income from Continuing Operations (Quarter)
-0.01M-15.81M4.62M-22.54M-22.00M-29.88M-30.88M-32.40M-49.88M-29.90M0.12M88.41M-28.21M-0.03M-26.86M0.05M-20.24M-21.36M
Consolidated Net Income (Quarter)
-0.01M-15.81M4.62M-22.54M-22.00M-29.88M-30.88M-32.40M-49.88M-29.90M0.12M88.41M-28.21M-0.03M-26.86M0.05M-20.24M-21.36M
Income towards Parent Company (Quarter)
-0.01M-15.81M4.62M-22.54M-22.00M-29.88M-30.88M-32.40M-49.88M-29.90M0.12M88.41M-28.21M-0.03M-26.86M0.05M-20.24M-21.36M
Net Income towards Common Stockholders (Quarter)
-14.01M-15.81M4.62M-22.54M-22.00M-29.88M-30.88M-32.40M-49.88M-29.49M-28.02M-29.90M-30.48M-28.73M-28.21M-31.22M-26.86M-30.52M-20.24M-21.36M
Additional items
EPS (Basic) (Quarter)
-7.03-8.171.86-9.00-8.45-11.64-11.50-12.07-18.57-10.96-5.67-5.28-5.37-5.23-4.96-5.48-4.72-4.43-1.88-1.99
EPS (Diluted) (Quarter)
-7.03-8.171.61-9.00-8.45-11.64-11.50-12.07-18.57-10.96-5.67-5.28-5.37-5.23-4.96-5.48-4.72-4.43-1.88-1.99
Shares Outstanding (Quarter)
1.99M1.93M2.49M2.50M2.60M2.57M2.68M2.68M2.69M2.69M4.94M5.66M5.68M5.49M5.69M5.69M5.69M6.89M10.74M10.75M
Shares Outstanding (Diluted) (Quarter)
1.99M1.93M2.87M2.50M2.60M2.57M2.68M2.68M2.69M2.69M4.94M5.66M5.68M5.49M5.69M5.69M5.69M6.89M10.74M10.75M
Shares Outstanding (Entity) (Quarter)
2.00M1.93M2.49M2.50M2.67M2.68M2.68M2.69M2.69M2.70M5.14M5.15M5.15M5.16M5.17M5.20M5.20M6.89M9.60M9.36M
EBITDA (Quarter)
-13.71M-15.54M4.71M-22.71M-22.98M-31.57M-33.32M-34.89M-52.26M-31.57M-30.87M-32.85M-33.15M-30.74M-29.89M-32.39M-27.95M-31.89M-21.57M-22.30M